China Pharma Holdings (CPHI) Assets Average (2011 - 2026)

China Pharma Holdings' Assets Average history runs 16 years deep, the most recent figure standing at $38.1 million for Q1 2026.

• Quarterly Assets Average rose 161.62% year-over-year to $38.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.1 million (up 161.62% YoY) and the FY2025 annual result came in at $22.9 million, up 46.34% from the prior year.
• Assets Average was $38.1 million for Q1 2026 at China Pharma Holdings, up from $23.4 million in the prior quarter.
• Across five years, Assets Average topped out at $38.1 million in Q1 2026 and bottomed at $13.9 million in Q3 2024.
• A 5-year average of $18.0 million and a median of $16.3 million in 2024 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2023 — Assets Average decreased 19.57% — and 2026, when it jumped 161.62%.
• China Pharma Holdings' Assets Average stood at $17.0 million in 2022, then slipped by 6.37% to $15.9 million in 2023, then dropped by 10.9% to $14.2 million in 2024, then jumped by 65.08% to $23.4 million in 2025, then jumped by 62.68% to $38.1 million in 2026.
• Business Quant data shows CPHI's Assets Average at $38.1 million in Q1 2026, $23.4 million in Q4 2025, and $14.8 million in Q3 2025.